Overexpression of IRF9 confers resistance to antimicrotubule agents in breast cancer cells

Cancer Research

Volumn 61, Issue 17, 2001, Pages 6540-6547

  Luker, Kathryn E ^a   Pica, Christina M ^a   Schreiber, Robert D ^a   Piwnica Worms, David ^a  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA INTERFERON; BETA INTERFERON; COMPLEMENTARY DNA; GENE PRODUCT; INTERFERON REGULATORY FACTOR 1; INTERFERON REGULATORY FACTOR 9; PACLITAXEL; STAT1 PROTEIN; STAT2 PROTEIN; UNCLASSIFIED DRUG;

ARTICLE; BREAST CANCER; CONTROLLED STUDY; GENE OVEREXPRESSION; GENETIC ANALYSIS; HUMAN; HUMAN CELL; PATHOGENESIS; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; TRANSCRIPTION REGULATION; UTERUS TUMOR;

ADENOCARCINOMA; ANTIBIOTICS, ANTINEOPLASTIC; ANTINEOPLASTIC AGENTS, PHYTOGENIC; BREAST NEOPLASMS; CELL CYCLE; DNA-BINDING PROTEINS; DOXORUBICIN; DRUG RESISTANCE, NEOPLASM; FEMALE; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; INTERFERON TYPE I; INTERFERON-STIMULATED GENE FACTOR 3; INTERFERON-STIMULATED GENE FACTOR 3, GAMMA SUBUNIT; MICROTUBULES; PACLITAXEL; SIGNAL TRANSDUCTION; TRANSCRIPTION FACTORS; TRANSFECTION; TUMOR CELLS, CULTURED; UTERINE NEOPLASMS; VINBLASTINE;

EID: 0035420016     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (58)

1. Exit from mitosis: Spindle pole power
2. Coupling cell division and cell death to microtubule dynamics
3. Localization of Mad2 to kinetochores depends on microtubule attachment, not tension
4. A senescence-like phenotype distinguishes tumor cells that undergo terminal proliferation arrest after exposure to anticancer agents
5. Cell cycle. Checkpoint on the nuclear frontier
6. The effect of antimicrotubule agents on signal transduction pathways of apoptosis: A review
7. Paclitaxel-induced cell death
8. Mechanisms of action of and resistance to antitubulin agents: Microtubule dynamics, drug transport, and cell death
9. Estrogen increases intracellular p26Bcl-2 to p21Bax ratios and inhibits Taxol-induced apoptosis of human breast cancer MCF-7 cells
10. 2-M arrest and apoptosis induced by paclitaxel in human sarcoma cells lacking both p53 and functional Rb protein
11. 2/M arrest and apoptosis
12. Overexpression of Bcl-XS sensitizes MCF-7 cells to chemotherapy-induced apoptosis
13. waf/cip1 in senescence-like terminal proliferation arrest induced in human tumor cells by chemotherapeutic drugs
14. 2 arrest after DNA damage
15. Isolation and genetic characterization of human KB cell lines resistant to multiple drugs
16. Resistance mechanisms in human sarcoma mutants derived by single-step exposure to paclitaxel (Taxol)
17. Mutations of bacteria from virus sensitivity to virus resistance
18. Pitfalls and practice of Luria-Delbrück fluctuation analysis: A review
19. 2) ethylenediamine-bis[propyl(R-benzylimino)]metal(III) cations
20. Characterization of phosphine complexes of technetium (III) as transport substrates of the multidrug resistance (MDR1) P-glycoprotein and functional markers of P-glycoprotein at the blood-brain barrier
21. Choroid plexus epithelial expression of MDR1 P-glycoprotein and multidrug resistance-associated protein contribute to the blood-cerebrospinal fluid drug-permeability barrier
22. Characterization of multidrug-resistance P-glycoprotein transport function with an organotechnetium cation
23. In vitro and in vivo reversal of multidrug resistance by GF120918, an acridonecarboxamide derivative
24. The antiviral state induced by α interferon and γ interferon requires transcriptionally active Stat1 protein
25. Basic local alignment search tool
26. MDR 1 activation is the predominant resistance mechanism selected by vinblastine in MES-SA cells
27. Paclitaxel-resistant human ovarian cancer cells have mutant β-tubulins that exhibit impaired paclitaxel-driven polymerization
28. Metal complexes for therapy and diagnosis of drug resistance
29. Biochemical, cellular, and pharmacological aspects of the multidrug transporter
30. Overexpression of a transporter gene in a multidrug-resistant human lung cancer cell line
31. Mitotic phosphorylation of bcl-2 during normal cell cycle progression and Taxol-induced growth arrest
32. Involvement of microtubules in the regulation of Bcl2 phosphorylation and apoptosis through cyclic AMP-dependent protein kinase
33. Relationship between paclitaxel activity and pathobiology of human solid tumors
34. Microtubule disfunction induced by paclitaxel initiates apoptosis through both c-Jun N-terminal kinase (JNK)-dependent and -independent pathways in ovarian cancer cells
35. Overex-pression of ErbB2 blocks Taxol-induced apoptosis by upregulation of p21Cip1, which inhibits p34Cdc2 kinase
36. Taxol-induced mitotic block triggers rapid onset of a p53-independent apoptotic pathway
37. Granzyme B mimics apical caspases. Description of a unified pathway for trans-activation of executioner caspase-3 and -7
38. Alteration of caspase-3 (CPP32/Yama/apopain) in wild-type MCF-7, breast cancer cells
39. Method of differential display
40. The proximal interferon-stimulated response elements are essential for interferon responsiveness: A promoter analysis of the antiviral MxA gene
41. Induction of the human gene for p44, a hepatitis-C-associated microtubular aggregate protein, by interferon-α/β
42. Identification of a new interferon-α-inducible gene (p27) on human chromosome 14q32 and its expression in breast carcinoma
43. Transactivation of classical and nonclassical HLA class I genes through the IFN-stimulated response element
44. α-Interferon-induced transcription of HLA and metallothionein genes containing homologous upstream sequences
45. How cells respond to interferons
46. Interferon regulatory factor subcellular localization is determined by a bipartite nuclear localization signal in the DNA-binding domain and interaction with cytoplasmic retention factors
47. Two domains of ISGF3-γ that mediate protein-DNA and protein-protein interactions during transcription factor assembly contribute to DNA-binding specificity
48. Interferon regulatory factors: The next generation
49. Combinatorial association and abundance of components of interferon-stimulated gene factor 3 dictate the selectivity of interferon responses
50. Stat2 is a transcriptional activator that requires sequence-specific contacts provided by stat1 and p48 for stable interaction with DNA
51. Retinoic acid induces signal transducer and activator of transcription (STAT) 1, STAT2, and p48 expression in myeloid leukemia cells and enhances their responsiveness to interferons
52. Interleukin-6 modulates interferon-regulated gene expression by inducing the ISGF3-γ gene using CCAAT/enhancer binding protein-β (C/EBP-β)
53. CD8(+) T cell-mediated skin disease in mice lacking IRF-2, the transcriptional attenuator of interferon-α/β signaling
54. Distinctive gene expression patterns in human mammary epithelial cells and breast cancers
55. Interferons, chemokines and other cytokines
56. Molecular portraits of human breast tumours
57. Elevated levels of members of the STAT family of transcription factors in breast carcinoma nuclear extracts
58. Activation of STAT transcription factors in oncogenic tyrosine kinase signaling